1-6 of 6
David C Taussig, PhD, MRCP, FRCPath
Close
Sort by
Journal Articles

SKIP Is Underexpressed in AML Leading to Sphingosine Kinase Hypofunction

Essam Ghazaly, MD PhD, Paul Smith, PhD, Chathunissa Gnanaranjan, MSc, Bryan D Young, BSc, PhD, Simon Joel, PhD, John G. Gribben, MD DSc, David C Taussig, PhD MRCP, FRCPath
Journal: Blood
Blood (2014) 124 (21): 5324.
https://doi.org/10.1182/blood.V124.21.5324.5324
Published: 2014
Journal Articles

Arginine Deprivation With Pegylated Arginine Deiminase Induces Death Of Acute Myeloid Leukaemia Cells In Vivo

Farideh Miraki-Moud, PhD, Linda Ariza-McNaughton, MSc, Essam A Ghazaly, MD, Katharine A Hodby, Phuong Luong, Andrew Clear, PhD, Fareeda Sohrabi, John Bomalaski, John Gribben, MD, DSc, Dominique Bonnet, PhD, Peter Szlosarek, David C Taussig, PhD, MRCP, FRCPath
Journal: Blood
Blood (2013) 122 (21): 1458.
https://doi.org/10.1182/blood.V122.21.1458.1458
Published: 2013
Journal Articles

Anergic Response to B-Cell Receptor Signaling in Chronic Lymphocytic Leukemia: The Differing Roles of IgD and IgM in the Microenvironment and Peripheral Blood.

Tom Butler, MD, Alexander Montoya, Andrew James Clear, BSc, Rita Coutinho, MD, David C Taussig, PhD, MRCP, FRCPath, Pedro Cutillas, PhD, John G Gribben
Journal: Blood
Blood (2012) 120 (21): 2889.
https://doi.org/10.1182/blood.V120.21.2889.2889
Published: 2012
Journal Articles

Human Primary Mantle Cell Lymphoma Can Be Established in NOD/SCID/IL2Rγ-Null Mice

Sunil Iyengar, MD, Linda Ariza-McNaughton, MSc, Andrew James Clear, BSc, Amy Roe, Debra Lillington, PhD, David C Taussig, PhD, MRCP, FRCPath, John G Gribben, Simon Joel, Dominique Bonnet, PhD
Journal: Blood
Blood (2012) 120 (21): 1565.
https://doi.org/10.1182/blood.V120.21.1565.1565
Published: 2012
Journal Articles

Continuous CD4+ T Cell Lines Derived From the Classical Hodgkin Lymphoma Microenvironment: A Challenge to the Assumption of Anergy,

Paul Greaves, Sameena Iqbal, David C Taussig, PhD, MRCP, FRCPath, John G. Gribben, MD, DSc
Journal: Blood
Blood (2011) 118 (21): 3645.
https://doi.org/10.1182/blood.V118.21.3645.3645
Published: 2011
Journal Articles

A Phase II Trial of Sequential Treatment with Cytoreductive Therapy and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukaemia, High-Risk MDS and Other High Risk Myeoid Malignancies: An Interim Report.

Dimitris A Tsitsikas, Dana Warcel-Sibony, Heather E. Oakervee, MBBS, BSc, MD, MRCP, FRCPath, Samir G Agrawal, Matthew Smith, David C Taussig, PhD, MRCP, FRCPath, Johannes de Vos, Elaine Stewart, Hannah Nicholas, John G. Gribben, MD, DSc, James D Cavenagh
Journal: Blood
Blood (2010) 116 (21): 3480.
https://doi.org/10.1182/blood.V116.21.3480.3480
Published: 2010